Translation of "évaluer le risque de préjudice de patients " (French → English) :

Instead of taking a risk assessment view, which basically asks how much risk is acceptable, the precautionary principle tells us that we should act to do as little harm as possible, and in doing so, to consider a full spectrum of alternatives to prevent and minimize harm.

I was referring to the principles of the IMIM, which provide that: it must always be applied in the context of a careful risk assessment; the risk assessment must take into account the likelihood and extent of loss of life, injury, and damage; the best strategy is the least intervention necessary to manage risk; and the best intervention causes the least harm or damage.

(ba) Informing patients about treatment risks and introducing legal mechanisms to facilitate the lodging of claims for damage to health, including against pharmaceutical companies.

As you're all aware, in our health care system, Health Canada, through the Medical Devices Bureau, which assesses products based on risk, looks at these products for safety and effectiveness, and we're concerned that some of the products wouldn't be able to meet those risk assessments and get to the patients.

Concerning the environmental risk assessment for Part C, risk management, labelling, monitoring, information to the public and safeguard clause, this Directive should be a point of reference for GMOs as or in products authorised by other Community legislation which should therefore provide for a specific environmental risk assessment, to be carried out in accordance with the principles set out in Annex II and on the basis of information specified in Annex III without prejudice ...[+++] to additional requirements laid down by the Community legislation mentioned above, and for requirements as regards risk management, labelling, monitoring as appropriate, information to the public and safeguard clause at least equivalent to that laid down in this Directive; the regulations to ensure that risk assessment and the requirements concerning risk management, labelling, monitoring as appropriate, information to the public and safeguard clause are equivalent to those laid down in this Directive should be implemented in cooperation with the relevant Commission services and national authorities responsible for the implementation of this Directive;

In response to the concerns raised with respect to the potential effect of Bill C-51 on the regulation of natural health products, the Government of Canada has posted information specific to Bill C-51 and natural health products on its “Healthy Canadians” website (25) The Government has also indicated that it will be proposing amendments to Bill C-51 once it has been referred to the House of Commons Standing Committee on Health (26) These amendments flow from “[e]xtensive stakeholder consultations [that] have been carried out to better understand [the] concerns [relating to the effect of Bill C-51 on natural health products] and to explain the underlying intent of the ch ...[+++]anges proposed in the Bill”.